AdvaMed Welcomes Formation of New Medtech Company Targeting Gastrointestinal Treatments
WASHINGTON, D.C.—Scott Whitaker, president and CEO of AdvaMed, the medtech association, made the following comment on the collaboration between Revival Healthcare Capital and Olympus Corporation to co-found Swan EndoSurgical, Inc. to develop a robotics platform to provide earlier, safer, and more effective treatment of lesions or tumors in the gastrointestinal tract relative to current therapeutic options.
“Two AdvaMed members announced a unique deal in the medtech space—the co-founding of a third company to develop a specific medical technology that holds promise in the gastroenterology space,” Whitaker said. “Olympus Corporation, which is based in Japan, and U.S.-based Revival Healthcare Capital will be investing in the United States, bringing good jobs and strengthening medtech’s already strong manufacturing and R&D presence in America. This is a good sign that the medtech ecosystem is getting stronger. Congratulations to AdvaMed board member Todd M. Pope and Robert J. White and their teams.”
The announcement of the new company’s formation is available here.